Alerts will be sent to your verified email
Verify Email
BROOKS
|
Brooks Laboratories
|
Vaidya Sane Ayur Lab
|
Lyka Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-21.13 % | 8.39 % | 62.44 % |
|
5yr average Equity Multiplier
|
1.68 | 1.34 | 2.9 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 1.57 | 0.73 |
|
5yr Avg Net Profit Margin
|
-21.45 % | 3.83 % | -0.79 % |
|
Price to Book
|
2.46 | 0.0 | 2.65 |
|
P/E
|
24.68 | 39.05 | 130.31 |
|
5yr Avg Cash Conversion Cycle
|
23.75 Days | -76.76 Days | 32.55 Days |
|
Inventory Days
|
83.11 Days | 11.33 Days | 24.2 Days |
|
Days Receivable
|
80.26 Days | 24.16 Days | 92.33 Days |
|
Days Payable
|
163.46 Days | 116.68 Days | 106.74 Days |
|
5yr Average Interest Coverage Ratio
|
-11.18 | 6.88 | 2.2 |
|
5yr Avg ROCE
|
-11.18 % | 12.91 % | 25.83 % |
|
5yr Avg Operating Profit Margin
|
-10.26 % | 7.94 % | 24.02 % |
|
5 yr average Debt to Equity
|
0.18 | 0.02 | 1.25 |
|
5yr CAGR Net Profit
|
-12.45 % | -10.61 % | n/a |
|
5yr Average Return on Assets
|
-13.31 % | 6.19 % | 1.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 66.34 % | 58.16 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | 0.0 | 10.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | 0.0 | -3.53 % |
|
Brooks Laboratories
|
Vaidya Sane Ayur Lab
|
Lyka Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|